메뉴 건너뛰기




Volumn 11, Issue 1, 2013, Pages

Basic research and clinical applications of bisphosphonates in bone disease: What have we learned over the last 40 years?

Author keywords

Bisphosphonate; Osteoblast; Osteoclast; Osteoporosis; Pharmacokinetics

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; CONNEXIN 43; ETIDRONIC ACID; ETIDRONIC ACID TC 99M; FLUORODEOXYGLUCOSE F 18; GERANYLTRANSFERASE; IBANDRONIC ACID; MEVALONIC ACID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RISEDRONIC ACID; ZOLEDRONIC ACID;

EID: 84889786252     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-303     Document Type: Review
Times cited : (68)

References (130)
  • 1
    • 79954441929 scopus 로고    scopus 로고
    • Current, new and future treatments of osteoporosis
    • 10.1007/s00296-010-1586-z, 20676643
    • Salari SP, Abdollahi M, Larijani B. Current, new and future treatments of osteoporosis. Rheumatol Int 2011, 31:289-300. 10.1007/s00296-010-1586-z, 20676643.
    • (2011) Rheumatol Int , vol.31 , pp. 289-300
    • Salari, S.P.1    Abdollahi, M.2    Larijani, B.3
  • 2
    • 79958703451 scopus 로고    scopus 로고
    • Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know
    • 10.1016/j.bone.2010.10.159, 20955825
    • Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone 2011, 49:56-65. 10.1016/j.bone.2010.10.159, 20955825.
    • (2011) Bone , vol.49 , pp. 56-65
    • Allen, M.R.1    Burr, D.B.2
  • 3
    • 84855328372 scopus 로고    scopus 로고
    • Paget's disease of bone
    • 10.1016/j.clinbiochem.2011.09.026, 22024254
    • Cundy T, Reid IR. Paget's disease of bone. Clin Biochem 2012, 45:43-48. 10.1016/j.clinbiochem.2011.09.026, 22024254.
    • (2012) Clin Biochem , vol.45 , pp. 43-48
    • Cundy, T.1    Reid, I.R.2
  • 4
    • 79958695940 scopus 로고    scopus 로고
    • Bisphosphonates: the first 40 years
    • 10.1016/j.bone.2011.04.022, 21555003
    • Russell RG. Bisphosphonates: the first 40 years. Bone 2011, 49:2-19. 10.1016/j.bone.2011.04.022, 21555003.
    • (2011) Bone , vol.49 , pp. 2-19
    • Russell, R.G.1
  • 5
    • 79958764505 scopus 로고    scopus 로고
    • Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability
    • 10.1016/j.bone.2010.08.008, 2994972, 20727997
    • Bellido T, Plotkin LI. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone 2011, 49:50-55. 10.1016/j.bone.2010.08.008, 2994972, 20727997.
    • (2011) Bone , vol.49 , pp. 50-55
    • Bellido, T.1    Plotkin, L.I.2
  • 6
    • 0033051107 scopus 로고    scopus 로고
    • Pharmacokinetics of alendronate
    • 10.2165/00003088-199936050-00002, 10384857
    • Porras AG, Holland SD, Gertz BJ. Pharmacokinetics of alendronate. Clin Pharmacokinet 1999, 36:315-328. 10.2165/00003088-199936050-00002, 10384857.
    • (1999) Clin Pharmacokinet , vol.36 , pp. 315-328
    • Porras, A.G.1    Holland, S.D.2    Gertz, B.J.3
  • 7
    • 22244432201 scopus 로고    scopus 로고
    • Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis
    • 10.2165/00003088-200544060-00001, 15932344
    • Cremers SC, Pillai G, Papapoulos SE. Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis. Clin Pharmacokinet 2005, 44:551-570. 10.2165/00003088-200544060-00001, 15932344.
    • (2005) Clin Pharmacokinet , vol.44 , pp. 551-570
    • Cremers, S.C.1    Pillai, G.2    Papapoulos, S.E.3
  • 8
    • 0035021131 scopus 로고    scopus 로고
    • Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease
    • 10.2165/00003495-200161050-00013, 11368289
    • Dunn CJ, Goa KL. Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease. Drugs 2001, 61:685-712. 10.2165/00003495-200161050-00013, 11368289.
    • (2001) Drugs , vol.61 , pp. 685-712
    • Dunn, C.J.1    Goa, K.L.2
  • 10
    • 0022643443 scopus 로고
    • Absorption of oral diphosphonate in normal subjects
    • 10.1111/j.1365-2265.1986.tb03254.x, 3085989
    • Fogelman I, Smith L, Mazess R, Wilson MA, Bevan JA. Absorption of oral diphosphonate in normal subjects. Clin Endocrinol (Oxf) 1986, 24:57-62. 10.1111/j.1365-2265.1986.tb03254.x, 3085989.
    • (1986) Clin Endocrinol (Oxf) , vol.24 , pp. 57-62
    • Fogelman, I.1    Smith, L.2    Mazess, R.3    Wilson, M.A.4    Bevan, J.A.5
  • 12
    • 0025164063 scopus 로고
    • Comparison of the distribution of three bisphosphonates in mice
    • 10.1111/j.1600-0773.1990.tb00750.x, 2142526
    • Monkkonen J, Koponen HM, Ylitalo P. Comparison of the distribution of three bisphosphonates in mice. Pharmacol Toxicol 1990, 66:294-298. 10.1111/j.1600-0773.1990.tb00750.x, 2142526.
    • (1990) Pharmacol Toxicol , vol.66 , pp. 294-298
    • Monkkonen, J.1    Koponen, H.M.2    Ylitalo, P.3
  • 13
    • 43049109229 scopus 로고    scopus 로고
    • Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
    • 10.1007/s00198-007-0540-8, 18214569
    • Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008, 19:733-759. 10.1007/s00198-007-0540-8, 18214569.
    • (2008) Osteoporos Int , vol.19 , pp. 733-759
    • Russell, R.G.1    Watts, N.B.2    Ebetino, F.H.3    Rogers, M.J.4
  • 14
    • 78650304661 scopus 로고    scopus 로고
    • Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class
    • 10.1016/j.bone.2010.07.016, 20655399
    • Clezardin P. Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class. Bone 2011, 48:71-79. 10.1016/j.bone.2010.07.016, 20655399.
    • (2011) Bone , vol.48 , pp. 71-79
    • Clezardin, P.1
  • 15
    • 0033796418 scopus 로고    scopus 로고
    • Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss
    • Carnevale V, Dicembrino F, Frusciante V, Chiodini I, Minisola S, Scillitani A. Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss. J Nucl Med 2000, 41:1478-1483.
    • (2000) J Nucl Med , vol.41 , pp. 1478-1483
    • Carnevale, V.1    Dicembrino, F.2    Frusciante, V.3    Chiodini, I.4    Minisola, S.5    Scillitani, A.6
  • 16
    • 0025787068 scopus 로고
    • In vivo SPECT quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis
    • Israel O, Front D, Hardoff R, Ish-Shalom S, Jerushalmi J, Kolodny GM. In vivo SPECT quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis. J Nucl Med 1991, 32:1157-1161.
    • (1991) J Nucl Med , vol.32 , pp. 1157-1161
    • Israel, O.1    Front, D.2    Hardoff, R.3    Ish-Shalom, S.4    Jerushalmi, J.5    Kolodny, G.M.6
  • 17
    • 0026320852 scopus 로고
    • Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
    • 10.1172/JCI115539, 295810, 1661297
    • Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991, 88:2095-2105. 10.1172/JCI115539, 295810, 1661297.
    • (1991) J Clin Invest , vol.88 , pp. 2095-2105
    • Sato, M.1    Grasser, W.2    Endo, N.3    Akins, R.4    Simmons, H.5    Thompson, D.D.6    Golub, E.7    Rodan, G.A.8
  • 18
    • 0026690327 scopus 로고
    • Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats
    • Lin JH, Chen IW, Duggan DE. Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats. Drug Metab Dispos 1992, 20:473-478.
    • (1992) Drug Metab Dispos , vol.20 , pp. 473-478
    • Lin, J.H.1    Chen, I.W.2    Duggan, D.E.3
  • 19
    • 1842405434 scopus 로고    scopus 로고
    • Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro
    • 10.1359/jbmr.1997.12.9.1358, 9286751
    • Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997, 12:1358-1367. 10.1359/jbmr.1997.12.9.1358, 9286751.
    • (1997) J Bone Miner Res , vol.12 , pp. 1358-1367
    • Frith, J.C.1    Monkkonen, J.2    Blackburn, G.M.3    Russell, R.G.4    Rogers, M.J.5
  • 20
    • 0029886359 scopus 로고    scopus 로고
    • Bisphosphonates: a review of their pharmacokinetic properties
    • 10.1016/8756-3282(95)00445-9, 8833200
    • Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996, 18:75-85. 10.1016/8756-3282(95)00445-9, 8833200.
    • (1996) Bone , vol.18 , pp. 75-85
    • Lin, J.H.1
  • 21
    • 77953517352 scopus 로고    scopus 로고
    • Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition
    • 10.1124/mi.10.3.5, 20539033
    • Drake MT, Cremers SC. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition. Mol Interv 2010, 10:141-152. 10.1124/mi.10.3.5, 20539033.
    • (2010) Mol Interv , vol.10 , pp. 141-152
    • Drake, M.T.1    Cremers, S.C.2
  • 22
    • 3042843179 scopus 로고    scopus 로고
    • The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)
    • 10.1359/jbmr.2004.19.1.147, 14753746
    • Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 2004, 19:147-154. 10.1359/jbmr.2004.19.1.147, 14753746.
    • (2004) J Bone Miner Res , vol.19 , pp. 147-154
    • Pan, B.1    Farrugia, A.N.2    To, L.B.3    Findlay, D.M.4    Green, J.5    Lynch, K.6    Zannettino, A.C.7
  • 23
    • 0036295812 scopus 로고    scopus 로고
    • Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts
    • 10.1006/bbrc.2002.6510, 11855844
    • Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Grundker C, Hofbauer LC. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 2002, 291:680-686. 10.1006/bbrc.2002.6510, 11855844.
    • (2002) Biochem Biophys Res Commun , vol.291 , pp. 680-686
    • Viereck, V.1    Emons, G.2    Lauck, V.3    Frosch, K.H.4    Blaschke, S.5    Grundker, C.6    Hofbauer, L.C.7
  • 24
    • 84864276811 scopus 로고    scopus 로고
    • Bisphosphonates: effects on osteoblast
    • 10.1007/s00228-012-1216-7, 22318756
    • Maruotti N, Corrado A, Neve A, Cantatore FP. Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol 2012, 68:1013-1018. 10.1007/s00228-012-1216-7, 22318756.
    • (2012) Eur J Clin Pharmacol , vol.68 , pp. 1013-1018
    • Maruotti, N.1    Corrado, A.2    Neve, A.3    Cantatore, F.P.4
  • 25
    • 84864281419 scopus 로고    scopus 로고
    • Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts
    • 10.1007/s00784-011-0614-z, 21938481
    • Ohe JY, Kwon YD, Lee HW. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. Clin Oral Investig 2012, 16:1153-1159. 10.1007/s00784-011-0614-z, 21938481.
    • (2012) Clin Oral Investig , vol.16 , pp. 1153-1159
    • Ohe, J.Y.1    Kwon, Y.D.2    Lee, H.W.3
  • 26
    • 84880636185 scopus 로고    scopus 로고
    • Prosthetic and biomechanical factors affecting bone remodeling around implants
    • Gracis S. Prosthetic and biomechanical factors affecting bone remodeling around implants. Eur J Esthet Dent 2013, 8:314-333.
    • (2013) Eur J Esthet Dent , vol.8 , pp. 314-333
    • Gracis, S.1
  • 27
    • 83455238176 scopus 로고    scopus 로고
    • Orthopaedics: Structural support
    • 10.1038/480S56a, 22169807
    • Berglund J. Orthopaedics: Structural support. Nature 2011, 480:S56-S57. 10.1038/480S56a, 22169807.
    • (2011) Nature , vol.480
    • Berglund, J.1
  • 28
    • 0026747622 scopus 로고
    • Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro
    • 10.1016/8756-3282(92)90205-B, 1637572
    • Tenenbaum HC, Torontali M, Sukhu B. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro. Bone 1992, 13:249-255. 10.1016/8756-3282(92)90205-B, 1637572.
    • (1992) Bone , vol.13 , pp. 249-255
    • Tenenbaum, H.C.1    Torontali, M.2    Sukhu, B.3
  • 29
    • 66649092722 scopus 로고    scopus 로고
    • Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells
    • 10.1177/147323000903700216, 19383235
    • Xiong Y, Yang HJ, Feng J, Shi ZL, Wu LD. Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. J Int Med Res 2009, 37:407-416. 10.1177/147323000903700216, 19383235.
    • (2009) J Int Med Res , vol.37 , pp. 407-416
    • Xiong, Y.1    Yang, H.J.2    Feng, J.3    Shi, Z.L.4    Wu, L.D.5
  • 30
    • 1642306206 scopus 로고    scopus 로고
    • Osteoblast proliferation and maturation by bisphosphonates
    • 10.1016/j.biomaterials.2003.11.024, 15046901
    • Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004, 25:4105-4115. 10.1016/j.biomaterials.2003.11.024, 15046901.
    • (2004) Biomaterials , vol.25 , pp. 4105-4115
    • Im, G.I.1    Qureshi, S.A.2    Kenney, J.3    Rubash, H.E.4    Shanbhag, A.S.5
  • 31
    • 70449532477 scopus 로고    scopus 로고
    • Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study
    • 10.1007/s11999-008-0409-y, 2772902, 18665432
    • Kim HK, Kim JH, Abbas AA, Yoon TR. Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study. Clin Orthop Relat Res 2009, 467:3121-3128. 10.1007/s11999-008-0409-y, 2772902, 18665432.
    • (2009) Clin Orthop Relat Res , vol.467 , pp. 3121-3128
    • Kim, H.K.1    Kim, J.H.2    Abbas, A.A.3    Yoon, T.R.4
  • 32
    • 33746768764 scopus 로고    scopus 로고
    • Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs
    • 10.1016/j.bone.2006.02.060, 16627025
    • Plotkin LI, Manolagas SC, Bellido T. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs. Bone 2006, 39:443-452. 10.1016/j.bone.2006.02.060, 16627025.
    • (2006) Bone , vol.39 , pp. 443-452
    • Plotkin, L.I.1    Manolagas, S.C.2    Bellido, T.3
  • 33
    • 54249141694 scopus 로고    scopus 로고
    • Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo
    • 10.1359/jbmr.080617, 2648607,2648607, 18597631
    • Plotkin LI, Lezcano V, Thostenson J, Weinstein RS, Manolagas SC, Bellido T. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res 2008, 23:1712-1721. 10.1359/jbmr.080617, 2648607,2648607, 18597631.
    • (2008) J Bone Miner Res , vol.23 , pp. 1712-1721
    • Plotkin, L.I.1    Lezcano, V.2    Thostenson, J.3    Weinstein, R.S.4    Manolagas, S.C.5    Bellido, T.6
  • 34
    • 0037040922 scopus 로고    scopus 로고
    • Transduction of cell survival signals by connexin-43 hemichannels
    • 10.1074/jbc.M108625200, 11741942
    • Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 2002, 277:8648-8657. 10.1074/jbc.M108625200, 11741942.
    • (2002) J Biol Chem , vol.277 , pp. 8648-8657
    • Plotkin, L.I.1    Manolagas, S.C.2    Bellido, T.3
  • 36
    • 84859259131 scopus 로고    scopus 로고
    • Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways
    • 10.1016/j.abb.2011.12.022, 3804299, 22230328
    • Lezcano V, Bellido T, Plotkin LI, Boland R, Morelli S. Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways. Arch Biochem Biophys 2012, 518:95-102. 10.1016/j.abb.2011.12.022, 3804299, 22230328.
    • (2012) Arch Biochem Biophys , vol.518 , pp. 95-102
    • Lezcano, V.1    Bellido, T.2    Plotkin, L.I.3    Boland, R.4    Morelli, S.5
  • 37
    • 84865662860 scopus 로고    scopus 로고
    • Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice
    • 10.1016/j.bone.2012.06.018, 3432742, 22750450
    • Watkins MP, Norris JY, Grimston SK, Zhang X, Phipps RJ, Ebetino FH, Civitelli R. Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice. Bone 2012, 51:787-794. 10.1016/j.bone.2012.06.018, 3432742, 22750450.
    • (2012) Bone , vol.51 , pp. 787-794
    • Watkins, M.P.1    Norris, J.Y.2    Grimston, S.K.3    Zhang, X.4    Phipps, R.J.5    Ebetino, F.H.6    Civitelli, R.7
  • 40
    • 79958736766 scopus 로고    scopus 로고
    • A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
    • 10.1016/j.bone.2010.08.011, 3010455, 20736091
    • Plotkin LI, Bivi N, Bellido T. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice. Bone 2011, 49:122-127. 10.1016/j.bone.2010.08.011, 3010455, 20736091.
    • (2011) Bone , vol.49 , pp. 122-127
    • Plotkin, L.I.1    Bivi, N.2    Bellido, T.3
  • 43
    • 0020687209 scopus 로고
    • Structure-activity relationships of various bisphosphonates
    • 10.1007/BF02405012, 6839194
    • Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P. Structure-activity relationships of various bisphosphonates. Calcif Tissue Int 1983, 35:87-99. 10.1007/BF02405012, 6839194.
    • (1983) Calcif Tissue Int , vol.35 , pp. 87-99
    • Shinoda, H.1    Adamek, G.2    Felix, R.3    Fleisch, H.4    Schenk, R.5    Hagan, P.6
  • 44
    • 0032942599 scopus 로고    scopus 로고
    • Bisphosphonates: pharmacology, mechanisms of action and clinical uses
    • Russell RG, Croucher PI, Rogers MJ. Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int 1999, 9(Suppl 2):S66-S80.
    • (1999) Osteoporos Int , vol.9 , Issue.SUPPL. 2
    • Russell, R.G.1    Croucher, P.I.2    Rogers, M.J.3
  • 45
    • 0029791778 scopus 로고    scopus 로고
    • 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase
    • Amin D, Cornell SA, Perrone MH, Bilder GE. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase. Arzneimittelforschung 1996, 46:759-762.
    • (1996) Arzneimittelforschung , vol.46 , pp. 759-762
    • Amin, D.1    Cornell, S.A.2    Perrone, M.H.3    Bilder, G.E.4
  • 46
  • 47
    • 84869407755 scopus 로고    scopus 로고
    • The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches
    • 10.1002/jcb.24301, 22833499
    • Soki FN, Li X, Berry J, Koh A, Sinder BP, Qian X, Kozloff KM, Taichman RS, McCauley LK. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches. J Cell Biochem 2013, 114:67-78. 10.1002/jcb.24301, 22833499.
    • (2013) J Cell Biochem , vol.114 , pp. 67-78
    • Soki, F.N.1    Li, X.2    Berry, J.3    Koh, A.4    Sinder, B.P.5    Qian, X.6    Kozloff, K.M.7    Taichman, R.S.8    McCauley, L.K.9
  • 48
    • 84555187826 scopus 로고    scopus 로고
    • Isolation and purification of rabbit osteoclasts
    • 10.1007/978-1-61779-415-5_10, 22130927
    • Coxon FP, Rogers MJ, Crockett JC. Isolation and purification of rabbit osteoclasts. Methods Mol Biol 2012, 816:145-158. 10.1007/978-1-61779-415-5_10, 22130927.
    • (2012) Methods Mol Biol , vol.816 , pp. 145-158
    • Coxon, F.P.1    Rogers, M.J.2    Crockett, J.C.3
  • 49
    • 84867074995 scopus 로고    scopus 로고
    • The effect of alendronate doped calcium phosphates on bone cells activity
    • 10.1016/j.bone.2012.07.020, 22878156
    • Boanini E, Torricelli P, Gazzano M, Fini M, Bigi A. The effect of alendronate doped calcium phosphates on bone cells activity. Bone 2012, 51:944-952. 10.1016/j.bone.2012.07.020, 22878156.
    • (2012) Bone , vol.51 , pp. 944-952
    • Boanini, E.1    Torricelli, P.2    Gazzano, M.3    Fini, M.4    Bigi, A.5
  • 50
    • 79958716455 scopus 로고    scopus 로고
    • Biochemical and molecular mechanisms of action of bisphosphonates
    • 10.1016/j.bone.2010.11.008, 21111853
    • Rogers MJ, Crockett JC, Coxon FP, Monkkonen J. Biochemical and molecular mechanisms of action of bisphosphonates. Bone 2011, 49:34-41. 10.1016/j.bone.2010.11.008, 21111853.
    • (2011) Bone , vol.49 , pp. 34-41
    • Rogers, M.J.1    Crockett, J.C.2    Coxon, F.P.3    Monkkonen, J.4
  • 51
    • 0031578907 scopus 로고    scopus 로고
    • Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry
    • 10.1016/S0378-4347(97)00490-8, 9518149
    • Auriola S, Frith J, Rogers MJ, Koivuniemi A, Monkkonen J. Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 1997, 704:187-195. 10.1016/S0378-4347(97)00490-8, 9518149.
    • (1997) J Chromatogr B Biomed Sci Appl , vol.704 , pp. 187-195
    • Auriola, S.1    Frith, J.2    Rogers, M.J.3    Koivuniemi, A.4    Monkkonen, J.5
  • 52
    • 0030601220 scopus 로고    scopus 로고
    • Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes
    • 10.1006/bbrc.1996.1113, 8713136
    • Rogers MJ, Brown RJ, Hodkin V, Blackburn GM, Russell RG, Watts DJ. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes. Biochem Biophys Res Commun 1996, 224:863-869. 10.1006/bbrc.1996.1113, 8713136.
    • (1996) Biochem Biophys Res Commun , vol.224 , pp. 863-869
    • Rogers, M.J.1    Brown, R.J.2    Hodkin, V.3    Blackburn, G.M.4    Russell, R.G.5    Watts, D.J.6
  • 53
    • 5444242637 scopus 로고    scopus 로고
    • Bisphosphonates: preclinical review
    • Green JR. Bisphosphonates: preclinical review. Oncologist 2004, 9(Suppl 4):3-13.
    • (2004) Oncologist , vol.9 , Issue.SUPPL. 4 , pp. 3-13
    • Green, J.R.1
  • 54
    • 78649842994 scopus 로고    scopus 로고
    • Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages
    • 10.2174/138161210793563635, 20722616
    • Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des 2010, 16:2950-2960. 10.2174/138161210793563635, 20722616.
    • (2010) Curr Pharm Des , vol.16 , pp. 2950-2960
    • Roelofs, A.J.1    Thompson, K.2    Ebetino, F.H.3    Rogers, M.J.4    Coxon, F.P.5
  • 55
    • 33750733277 scopus 로고    scopus 로고
    • Molecular mechanisms of action of bisphosphonates: current status
    • 10.1158/1078-0432.CCR-06-0843, 17062705
    • Roelofs AJ, Thompson K, Gordon S, Rogers MJ. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 2006, 12:6222s-6230s. 10.1158/1078-0432.CCR-06-0843, 17062705.
    • (2006) Clin Cancer Res , vol.12
    • Roelofs, A.J.1    Thompson, K.2    Gordon, S.3    Rogers, M.J.4
  • 56
    • 0014394588 scopus 로고
    • The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution
    • Fleisch H, Russell RG, Bisaz S, Casey PA, Muhlbauer RC. The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution. Calcif Tissue Res 1968, suppl:10-10a.
    • (1968) Calcif Tissue Res , Issue.SUPPL.
    • Fleisch, H.1    Russell, R.G.2    Bisaz, S.3    Casey, P.A.4    Muhlbauer, R.C.5
  • 57
    • 84874398318 scopus 로고    scopus 로고
    • Biomedical applications of bisphosphonates
    • 10.1016/j.jconrel.2013.01.032, 23395668
    • Giger EV, Castagner B, Leroux JC. Biomedical applications of bisphosphonates. J Control Release 2013, 167:175-188. 10.1016/j.jconrel.2013.01.032, 23395668.
    • (2013) J Control Release , vol.167 , pp. 175-188
    • Giger, E.V.1    Castagner, B.2    Leroux, J.C.3
  • 58
    • 0016835613 scopus 로고
    • Technetium-99 m-methylene diphosphonate-a superior agent for skeletal imaging: comparison with other technetium complexes
    • Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD. Technetium-99 m-methylene diphosphonate-a superior agent for skeletal imaging: comparison with other technetium complexes. J Nucl Med 1975, 16:744-755.
    • (1975) J Nucl Med , vol.16 , pp. 744-755
    • Subramanian, G.1    McAfee, J.G.2    Blair, R.J.3    Kallfelz, F.A.4    Thomas, F.D.5
  • 59
    • 84875798241 scopus 로고    scopus 로고
    • Dynamic bone imaging with 99mTc-labeled diphosphonates and 18 F-NaF: mechanisms and applications
    • 10.2967/jnumed.112.114298, 23482667
    • Wong KK, Piert M. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18 F-NaF: mechanisms and applications. J Nucl Med 2013, 54:590-599. 10.2967/jnumed.112.114298, 23482667.
    • (2013) J Nucl Med , vol.54 , pp. 590-599
    • Wong, K.K.1    Piert, M.2
  • 61
    • 84866849630 scopus 로고    scopus 로고
    • Skeletal complications of bisphosphonate use: what the radiologist should know
    • 10.1259/bjr/99102700, 3474040, 22972971
    • Haworth AE, Webb J. Skeletal complications of bisphosphonate use: what the radiologist should know. Br J Radiol 2012, 85:1333-1342. 10.1259/bjr/99102700, 3474040, 22972971.
    • (2012) Br J Radiol , vol.85 , pp. 1333-1342
    • Haworth, A.E.1    Webb, J.2
  • 64
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
    • 10.1001/jama.282.14.1344, 10527181
    • Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CR, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999, 282:1344-1352. 10.1001/jama.282.14.1344, 10527181.
    • (1999) JAMA , vol.282 , pp. 1344-1352
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3    McKeever, C.D.4    Hangartner, T.5    Keller, M.6    Chesnut, C.R.7    Brown, J.8    Eriksen, E.F.9    Hoseyni, M.S.10    Axelrod, D.W.11    Miller, P.D.12
  • 66
    • 84881160693 scopus 로고    scopus 로고
    • Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis
    • 10.1007/s11096-013-9784-x, 23677816
    • Lai PS, Chua SS, Chan SP. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm 2013, 35:629-637. 10.1007/s11096-013-9784-x, 23677816.
    • (2013) Int J Clin Pharm , vol.35 , pp. 629-637
    • Lai, P.S.1    Chua, S.S.2    Chan, S.P.3
  • 68
    • 84867336111 scopus 로고    scopus 로고
    • New therapeutic targets for osteoporosis: beyond denosumab
    • 10.1016/j.maturitas.2012.08.002, 22925430
    • Lim V, Clarke BL. New therapeutic targets for osteoporosis: beyond denosumab. Maturitas 2012, 73:269-272. 10.1016/j.maturitas.2012.08.002, 22925430.
    • (2012) Maturitas , vol.73 , pp. 269-272
    • Lim, V.1    Clarke, B.L.2
  • 71
    • 84876063550 scopus 로고    scopus 로고
    • Effects of zoledronic acid on odontoblast-like cells
    • 10.1016/j.archoralbio.2012.09.016, 23092609
    • Basso FG, Turrioni AP, Hebling J, de Souza CC. Effects of zoledronic acid on odontoblast-like cells. Arch Oral Biol 2013, 58:467-473. 10.1016/j.archoralbio.2012.09.016, 23092609.
    • (2013) Arch Oral Biol , vol.58 , pp. 467-473
    • Basso, F.G.1    Turrioni, A.P.2    Hebling, J.3    de Souza, C.C.4
  • 72
    • 78751470118 scopus 로고    scopus 로고
    • The role of occupational therapists and physical therapists in elementary school system early intervening services and response to intervention: a case report
    • 10.3109/01942638.2010.497180, 20735199
    • Reeder DL, Arnold SH, Jeffries LM, McEwen IR. The role of occupational therapists and physical therapists in elementary school system early intervening services and response to intervention: a case report. Phys Occup Ther Pediatr 2011, 31:44-57. 10.3109/01942638.2010.497180, 20735199.
    • (2011) Phys Occup Ther Pediatr , vol.31 , pp. 44-57
    • Reeder, D.L.1    Arnold, S.H.2    Jeffries, L.M.3    McEwen, I.R.4
  • 74
    • 58849119154 scopus 로고    scopus 로고
    • Cancer treatment-related bone disease
    • 10.1615/CritRevEukarGeneExpr.v19.i1.20, 2762110, 19191756
    • Brown SA, Guise TA. Cancer treatment-related bone disease. Crit Rev Eukaryot Gene Expr 2009, 19:47-60. 10.1615/CritRevEukarGeneExpr.v19.i1.20, 2762110, 19191756.
    • (2009) Crit Rev Eukaryot Gene Expr , vol.19 , pp. 47-60
    • Brown, S.A.1    Guise, T.A.2
  • 75
    • 78349235413 scopus 로고    scopus 로고
    • The crossover of bisphosphonates to cancer therapy
    • 10.1111/j.1749-6632.2010.05812.x, 21062299
    • Sun M, Iqbal J, Singh S, Sun L, Zaidi M. The crossover of bisphosphonates to cancer therapy. Ann N Y Acad Sci 2010, 1211:107-112. 10.1111/j.1749-6632.2010.05812.x, 21062299.
    • (2010) Ann N Y Acad Sci , vol.1211 , pp. 107-112
    • Sun, M.1    Iqbal, J.2    Singh, S.3    Sun, L.4    Zaidi, M.5
  • 76
    • 77953488144 scopus 로고    scopus 로고
    • Mitochondria as decision-makers in cell death
    • Borutaite V. Mitochondria as decision-makers in cell death. Environ Mol Mutagen 2010, 51:406-416.
    • (2010) Environ Mol Mutagen , vol.51 , pp. 406-416
    • Borutaite, V.1
  • 77
    • 84856240436 scopus 로고    scopus 로고
    • Potential anticancer properties of bisphosphonates: insights from preclinical studies
    • 10.2174/187152012799014977, 21864232
    • Clezardin P. Potential anticancer properties of bisphosphonates: insights from preclinical studies. Anticancer Agents Med Chem 2012, 12:102-113. 10.2174/187152012799014977, 21864232.
    • (2012) Anticancer Agents Med Chem , vol.12 , pp. 102-113
    • Clezardin, P.1
  • 78
    • 79958756501 scopus 로고    scopus 로고
    • Bisphosphonates in preclinical bone oncology
    • 10.1016/j.bone.2010.11.017, 21145441
    • Clezardin P, Benzaid I, Croucher PI. Bisphosphonates in preclinical bone oncology. Bone 2011, 49:66-70. 10.1016/j.bone.2010.11.017, 21145441.
    • (2011) Bone , vol.49 , pp. 66-70
    • Clezardin, P.1    Benzaid, I.2    Croucher, P.I.3
  • 83
    • 56749165071 scopus 로고    scopus 로고
    • Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up
    • 10.1093/annonc/mdn429, 2733118, 18664560
    • Diel IJ, Jaschke A, Solomayer EF, Gollan C, Bastert G, Sohn C, Schuetz F. Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up. Ann Oncol 2008, 19:2007-2011. 10.1093/annonc/mdn429, 2733118, 18664560.
    • (2008) Ann Oncol , vol.19 , pp. 2007-2011
    • Diel, I.J.1    Jaschke, A.2    Solomayer, E.F.3    Gollan, C.4    Bastert, G.5    Sohn, C.6    Schuetz, F.7
  • 84
    • 77954580167 scopus 로고    scopus 로고
    • Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
    • 10.1093/annonc/mdq217, 20444845
    • Eidtmann H, de Boer R, Bundred N, Llombart-Cussac A, Davidson N, Neven P, von Minckwitz G, Miller J, Schenk N, Coleman R. Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol 2010, 21:2188-2194. 10.1093/annonc/mdq217, 20444845.
    • (2010) Ann Oncol , vol.21 , pp. 2188-2194
    • Eidtmann, H.1    de Boer, R.2    Bundred, N.3    Llombart-Cussac, A.4    Davidson, N.5    Neven, P.6    von Minckwitz, G.7    Miller, J.8    Schenk, N.9    Coleman, R.10
  • 85
    • 78649897872 scopus 로고    scopus 로고
    • Alternative use of bisphosphonate therapy for rheumatic disease
    • 10.2174/138161210793563626, 20722620
    • Le Goff B, Berthelot JM, Maugars Y, Romas E. Alternative use of bisphosphonate therapy for rheumatic disease. Curr Pharm Des 2010, 16:3045-3052. 10.2174/138161210793563626, 20722620.
    • (2010) Curr Pharm Des , vol.16 , pp. 3045-3052
    • Le Goff, B.1    Berthelot, J.M.2    Maugars, Y.3    Romas, E.4
  • 86
    • 38749090979 scopus 로고    scopus 로고
    • Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis
    • Suzuki Y. Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis. Clin Calcium 2007, 17:1909-1913.
    • (2007) Clin Calcium , vol.17 , pp. 1909-1913
    • Suzuki, Y.1
  • 87
    • 77954535372 scopus 로고    scopus 로고
    • The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
    • 10.1007/s00198-010-1192-7, 20229200
    • Edwards CJ, Williams E. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporos Int 2010, 21:1287-1293. 10.1007/s00198-010-1192-7, 20229200.
    • (2010) Osteoporos Int , vol.21 , pp. 1287-1293
    • Edwards, C.J.1    Williams, E.2
  • 88
    • 0032703282 scopus 로고    scopus 로고
    • Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate
    • Cantatore FP, Acquista CA, Pipitone V. Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. J Rheumatol 1999, 26:2318-2323.
    • (1999) J Rheumatol , vol.26 , pp. 2318-2323
    • Cantatore, F.P.1    Acquista, C.A.2    Pipitone, V.3
  • 89
    • 0037333914 scopus 로고    scopus 로고
    • Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis
    • Hasegawa J, Nagashima M, Yamamoto M, Nishijima T, Katsumata S, Yoshino S. Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. J Rheumatol 2003, 30:474-479.
    • (2003) J Rheumatol , vol.30 , pp. 474-479
    • Hasegawa, J.1    Nagashima, M.2    Yamamoto, M.3    Nishijima, T.4    Katsumata, S.5    Yoshino, S.6
  • 90
    • 0036623621 scopus 로고    scopus 로고
    • Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers
    • 10.1007/BF03324436, 12387527
    • Mazzantini M, Di Munno O, Metelli MR, Bulleri M, Giordani R. Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers. Aging Clin Exp Res 2002, 14:197-201. 10.1007/BF03324436, 12387527.
    • (2002) Aging Clin Exp Res , vol.14 , pp. 197-201
    • Mazzantini, M.1    Di Munno, O.2    Metelli, M.R.3    Bulleri, M.4    Giordani, R.5
  • 91
    • 0033760598 scopus 로고    scopus 로고
    • Anti-inflammatory and immunomodulatory therapies in spondyloarthropathies
    • Maksymowych WP. Anti-inflammatory and immunomodulatory therapies in spondyloarthropathies. Curr Opin Investig Drugs 2000, 1:63-69.
    • (2000) Curr Opin Investig Drugs , vol.1 , pp. 63-69
    • Maksymowych, W.P.1
  • 92
    • 67650070025 scopus 로고    scopus 로고
    • Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid
    • 10.1093/rheumatology/kep084, 19406908
    • Rossini M, Viapiana O, Ramonda R, Bianchi G, Olivieri I, Lapadula G, Adami S. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) 2009, 48:773-778. 10.1093/rheumatology/kep084, 19406908.
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 773-778
    • Rossini, M.1    Viapiana, O.2    Ramonda, R.3    Bianchi, G.4    Olivieri, I.5    Lapadula, G.6    Adami, S.7
  • 94
    • 84868094056 scopus 로고    scopus 로고
    • Evaluation of gastric ulcerogenic and healing impairment effects of bisphosphonates: adverse gastric reactions of bisphosphonate
    • Takeuchi K, Amagase K. Evaluation of gastric ulcerogenic and healing impairment effects of bisphosphonates: adverse gastric reactions of bisphosphonate. Curr Protoc Toxicol 2012, 21:10-21.
    • (2012) Curr Protoc Toxicol , vol.21 , pp. 10-21
    • Takeuchi, K.1    Amagase, K.2
  • 95
    • 84858062241 scopus 로고    scopus 로고
    • An evaluation of the use of oral bisphosphonates and risk of esophageal cancer
    • 10.1345/aph.1Q482, 22333262
    • Haber SL, McNatty D. An evaluation of the use of oral bisphosphonates and risk of esophageal cancer. Ann Pharmacother 2012, 46:419-423. 10.1345/aph.1Q482, 22333262.
    • (2012) Ann Pharmacother , vol.46 , pp. 419-423
    • Haber, S.L.1    McNatty, D.2
  • 96
    • 0042707523 scopus 로고    scopus 로고
    • Pharmacovigilance study of alendronate in England
    • 10.1007/s00198-003-1399-y, 12730757
    • Biswas PN, Wilton LV, Shakir SA. Pharmacovigilance study of alendronate in England. Osteoporos Int 2003, 14:507-514. 10.1007/s00198-003-1399-y, 12730757.
    • (2003) Osteoporos Int , vol.14 , pp. 507-514
    • Biswas, P.N.1    Wilton, L.V.2    Shakir, S.A.3
  • 97
    • 0042861578 scopus 로고    scopus 로고
    • Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic
    • 10.1016/S0278-2391(03)00720-1, 12966493
    • Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003, 61:1115-1117. 10.1016/S0278-2391(03)00720-1, 12966493.
    • (2003) J Oral Maxillofac Surg , vol.61 , pp. 1115-1117
    • Marx, R.E.1
  • 98
    • 2142817155 scopus 로고    scopus 로고
    • Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
    • 10.1016/j.joms.2004.02.004, 15122554
    • Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004, 62:527-534. 10.1016/j.joms.2004.02.004, 15122554.
    • (2004) J Oral Maxillofac Surg , vol.62 , pp. 527-534
    • Ruggiero, S.L.1    Mehrotra, B.2    Rosenberg, T.J.3    Engroff, S.L.4
  • 99
    • 84873042388 scopus 로고    scopus 로고
    • Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy
    • Janovska Z. Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy. Acta Medica (Hradec Kralove) 2012, 55:111-115.
    • (2012) Acta Medica (Hradec Kralove) , vol.55 , pp. 111-115
    • Janovska, Z.1
  • 100
    • 84865223824 scopus 로고    scopus 로고
    • Dental implications of bisphophonate-related osteonecrosis
    • 10.1111/j.1741-2358.2012.00622.x, 22486711
    • Saldanha S, Shenoy VK, Eachampati P, Uppal N. Dental implications of bisphophonate-related osteonecrosis. Gerodontology 2012, 29:177-187. 10.1111/j.1741-2358.2012.00622.x, 22486711.
    • (2012) Gerodontology , vol.29 , pp. 177-187
    • Saldanha, S.1    Shenoy, V.K.2    Eachampati, P.3    Uppal, N.4
  • 101
    • 84857698579 scopus 로고    scopus 로고
    • Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients
    • 10.1111/j.1600-0714.2011.01091.x, 21958312
    • Vescovi P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S. Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med 2012, 41:214-221. 10.1111/j.1600-0714.2011.01091.x, 21958312.
    • (2012) J Oral Pathol Med , vol.41 , pp. 214-221
    • Vescovi, P.1    Merigo, E.2    Meleti, M.3    Manfredi, M.4    Guidotti, R.5    Nammour, S.6
  • 102
    • 84855474528 scopus 로고    scopus 로고
    • Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review
    • 10.1016/j.surge.2011.09.002, 22233554
    • McLeod NM, Brennan PA, Ruggiero SL. Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review. Surgeon 2012, 10:36-42. 10.1016/j.surge.2011.09.002, 22233554.
    • (2012) Surgeon , vol.10 , pp. 36-42
    • McLeod, N.M.1    Brennan, P.A.2    Ruggiero, S.L.3
  • 103
    • 79959325491 scopus 로고    scopus 로고
    • Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw
    • 10.1016/j.bjoms.2010.08.005, 20863603
    • McLeod NM, Patel V, Kusanale A, Rogers SN, Brennan PA. Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw. Br J Oral Maxillofac Surg 2011, 49:335-342. 10.1016/j.bjoms.2010.08.005, 20863603.
    • (2011) Br J Oral Maxillofac Surg , vol.49 , pp. 335-342
    • McLeod, N.M.1    Patel, V.2    Kusanale, A.3    Rogers, S.N.4    Brennan, P.A.5
  • 104
    • 54249151531 scopus 로고    scopus 로고
    • Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer
    • 10.1200/JCO.2008.16.4707, 2653138, 18711172
    • Hershman DL, McMahon DJ, Crew KD, Cremers S, Irani D, Cucchiara G, Brafman L, Shane E. Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2008, 26:4739-4745. 10.1200/JCO.2008.16.4707, 2653138, 18711172.
    • (2008) J Clin Oncol , vol.26 , pp. 4739-4745
    • Hershman, D.L.1    McMahon, D.J.2    Crew, K.D.3    Cremers, S.4    Irani, D.5    Cucchiara, G.6    Brafman, L.7    Shane, E.8
  • 105
    • 0038075478 scopus 로고    scopus 로고
    • Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
    • 10.1097/01.ju.0000063820.94994.95, 12771706
    • Smith MR, Eastham J, Gleason DM, Shasha D, Tchekmedyian S, Zinner N. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol 2003, 169:2008-2012. 10.1097/01.ju.0000063820.94994.95, 12771706.
    • (2003) J Urol , vol.169 , pp. 2008-2012
    • Smith, M.R.1    Eastham, J.2    Gleason, D.M.3    Shasha, D.4    Tchekmedyian, S.5    Zinner, N.6
  • 107
    • 34247892446 scopus 로고    scopus 로고
    • Alendronate and atrial fibrillation
    • 10.1056/NEJMc076132, 17476024
    • Cummings SR, Schwartz AV, Black DM. Alendronate and atrial fibrillation. N Engl J Med 2007, 356:1895-1896. 10.1056/NEJMc076132, 17476024.
    • (2007) N Engl J Med , vol.356 , pp. 1895-1896
    • Cummings, S.R.1    Schwartz, A.V.2    Black, D.M.3
  • 108
    • 34547944533 scopus 로고    scopus 로고
    • Yearly zoledronic acid in postmenopausal osteoporosis
    • 714-715
    • Karam R, Camm J, McClung M. Yearly zoledronic acid in postmenopausal osteoporosis. N Engl J Med 2007, 357:712-713. 714-715.
    • (2007) N Engl J Med , vol.357 , pp. 712-713
    • Karam, R.1    Camm, J.2    McClung, M.3
  • 109
    • 77950660843 scopus 로고    scopus 로고
    • Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials
    • 10.1111/j.1742-1241.2010.02335.x, 20337751
    • Lewiecki EM, Cooper C, Thompson E, Hartl F, Mehta D, Papapoulos SE. Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials. Int J Clin Pract 2010, 64:821-826. 10.1111/j.1742-1241.2010.02335.x, 20337751.
    • (2010) Int J Clin Pract , vol.64 , pp. 821-826
    • Lewiecki, E.M.1    Cooper, C.2    Thompson, E.3    Hartl, F.4    Mehta, D.5    Papapoulos, S.E.6
  • 110
    • 42949145038 scopus 로고    scopus 로고
    • Use of alendronate and risk of incident atrial fibrillation in women
    • 10.1001/archinte.168.8.826, 18443257
    • Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008, 168:826-831. 10.1001/archinte.168.8.826, 18443257.
    • (2008) Arch Intern Med , vol.168 , pp. 826-831
    • Heckbert, S.R.1    Li, G.2    Cummings, S.R.3    Smith, N.L.4    Psaty, B.M.5
  • 111
    • 77952523378 scopus 로고    scopus 로고
    • Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice
    • 10.1007/s00774-009-0128-9, 19882100
    • Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K, Yatani H, Yoneda T. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab 2010, 28:165-175. 10.1007/s00774-009-0128-9, 19882100.
    • (2010) J Bone Miner Metab , vol.28 , pp. 165-175
    • Kobayashi, Y.1    Hiraga, T.2    Ueda, A.3    Wang, L.4    Matsumoto-Nakano, M.5    Hata, K.6    Yatani, H.7    Yoneda, T.8
  • 113
    • 84878113321 scopus 로고    scopus 로고
    • Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?
    • 10.1016/j.joms.2012.12.005, 23489958
    • Kos M, Junka A, Smutnicka D, Bartoszewicz M, Kurzynowski T, Gluza K. Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?. J Oral Maxillofac Surg 2013, 71:1010-1016. 10.1016/j.joms.2012.12.005, 23489958.
    • (2013) J Oral Maxillofac Surg , vol.71 , pp. 1010-1016
    • Kos, M.1    Junka, A.2    Smutnicka, D.3    Bartoszewicz, M.4    Kurzynowski, T.5    Gluza, K.6
  • 114
    • 65949103196 scopus 로고    scopus 로고
    • More on reports of esophageal cancer with oral bisphosphonate use
    • 1791-1792
    • Solomon DH, Patrick A, Brookhart MA. More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med 2009, 360:1789-1790. 1791-1792.
    • (2009) N Engl J Med , vol.360 , pp. 1789-1790
    • Solomon, D.H.1    Patrick, A.2    Brookhart, M.A.3
  • 115
    • 79956219064 scopus 로고    scopus 로고
    • Bisphosphonate related osteonecrosis of the jaw-manifestation in a microvascular iliac bone flap
    • 10.1016/j.oraloncology.2011.03.022, 21478047
    • Pautke C, Otto S, Reu S, Kolk A, Ehrenfeld M, Sturzenbaum S, Wolff KD. Bisphosphonate related osteonecrosis of the jaw-manifestation in a microvascular iliac bone flap. Oral Oncol 2011, 47:425-429. 10.1016/j.oraloncology.2011.03.022, 21478047.
    • (2011) Oral Oncol , vol.47 , pp. 425-429
    • Pautke, C.1    Otto, S.2    Reu, S.3    Kolk, A.4    Ehrenfeld, M.5    Sturzenbaum, S.6    Wolff, K.D.7
  • 117
    • 38749135807 scopus 로고    scopus 로고
    • An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    • 10.1016/j.injury.2007.08.036, 18222447
    • Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury 2008, 39:224-231. 10.1016/j.injury.2007.08.036, 18222447.
    • (2008) Injury , vol.39 , pp. 224-231
    • Kwek, E.B.1    Goh, S.K.2    Koh, J.S.3    Png, M.A.4    Howe, T.S.5
  • 118
    • 40949099444 scopus 로고    scopus 로고
    • Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
    • 10.1056/NEJMc0707493, 18354114
    • Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008, 358:1304-1306. 10.1056/NEJMc0707493, 18354114.
    • (2008) N Engl J Med , vol.358 , pp. 1304-1306
    • Lenart, B.A.1    Lorich, D.G.2    Lane, J.M.3
  • 119
    • 49249117414 scopus 로고    scopus 로고
    • Severely suppressed bone turnover and atypical skeletal fragility
    • 10.1210/jc.2007-2803, 18522980
    • Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 2008, 93:2948-2952. 10.1210/jc.2007-2803, 18522980.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2948-2952
    • Visekruna, M.1    Wilson, D.2    McKiernan, F.E.3
  • 120
    • 77956283668 scopus 로고    scopus 로고
    • Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack
    • 10.3109/17453674.2010.492766, 2917569, 20515438
    • Aspenberg P, Schilcher J, Fahlgren A. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack. Acta Orthop 2010, 81:460-462. 10.3109/17453674.2010.492766, 2917569, 20515438.
    • (2010) Acta Orthop , vol.81 , pp. 460-462
    • Aspenberg, P.1    Schilcher, J.2    Fahlgren, A.3
  • 122
    • 79955722153 scopus 로고    scopus 로고
    • Bisphosphonate use and atypical fractures of the femoral shaft
    • 10.1056/NEJMoa1010650, 21542743
    • Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011, 364:1728-1737. 10.1056/NEJMoa1010650, 21542743.
    • (2011) N Engl J Med , vol.364 , pp. 1728-1737
    • Schilcher, J.1    Michaelsson, K.2    Aspenberg, P.3
  • 124
    • 84877065670 scopus 로고    scopus 로고
    • Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy
    • 10.1016/j.bone.2013.03.018, 23567160
    • Allison MB, Markman L, Rosenberg Z, Vieira RL, Babb J, Tejwani N, Peck V. Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy. Bone 2013, 55:113-118. 10.1016/j.bone.2013.03.018, 23567160.
    • (2013) Bone , vol.55 , pp. 113-118
    • Allison, M.B.1    Markman, L.2    Rosenberg, Z.3    Vieira, R.L.4    Babb, J.5    Tejwani, N.6    Peck, V.7
  • 125
    • 79954988988 scopus 로고    scopus 로고
    • Safety of long-term bisphosphonate therapy for the management of osteoporosis
    • 10.2165/11585470-000000000-00000, 21504254
    • Lewiecki EM. Safety of long-term bisphosphonate therapy for the management of osteoporosis. Drugs 2011, 71:791-814. 10.2165/11585470-000000000-00000, 21504254.
    • (2011) Drugs , vol.71 , pp. 791-814
    • Lewiecki, E.M.1
  • 126
    • 77956542068 scopus 로고    scopus 로고
    • Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort
    • 10.1136/bmj.c4444, 2933354, 20813820
    • Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 2010, 341:c4444. 10.1136/bmj.c4444, 2933354, 20813820.
    • (2010) BMJ , vol.341
    • Green, J.1    Czanner, G.2    Reeves, G.3    Watson, J.4    Wise, L.5    Beral, V.6
  • 127
    • 65949103196 scopus 로고    scopus 로고
    • More on reports of esophageal cancer with oral bisphosphonate use
    • 1791-1792
    • Abrahamsen B, Eiken P, Eastell R. More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med 2009, 360:1789. 1791-1792.
    • (2009) N Engl J Med , vol.360 , pp. 1789
    • Abrahamsen, B.1    Eiken, P.2    Eastell, R.3
  • 129
    • 39749155815 scopus 로고    scopus 로고
    • Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results
    • 10.1002/cncr.23259, 18205185
    • Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, Monnier A, Neven P, von Minckwitz G, Miller JC, Schenk NL, Coleman RE. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. Cancer 2008, 112:1001-1010. 10.1002/cncr.23259, 18205185.
    • (2008) Cancer , vol.112 , pp. 1001-1010
    • Bundred, N.J.1    Campbell, I.D.2    Davidson, N.3    DeBoer, R.H.4    Eidtmann, H.5    Monnier, A.6    Neven, P.7    von Minckwitz, G.8    Miller, J.C.9    Schenk, N.L.10    Coleman, R.E.11
  • 130
    • 78149411581 scopus 로고    scopus 로고
    • Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study
    • 10.1007/s00198-009-1143-3, 19997902
    • Lamberg AL, Horvath-Puho E, Christensen S, Sorensen HT. Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study. Osteoporos Int 2010, 21:1911-1917. 10.1007/s00198-009-1143-3, 19997902.
    • (2010) Osteoporos Int , vol.21 , pp. 1911-1917
    • Lamberg, A.L.1    Horvath-Puho, E.2    Christensen, S.3    Sorensen, H.T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.